4-(4-甲酰苯基)苯甲酸甲酯 | 70916-89-1

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(4-甲酰苯基)苯甲酸甲酯
• 中文别名: 4'-甲酰基联苯-4-羧酸甲酯；4'-甲酸基联苯-4-羧酸甲酯
• 英文名称: methyl 4-(4-formylphenyl)benzoate
• 英文别名: methyl 4'-formyl-[1,1'-biphenyl]-4-carboxylate；4'-formylbiphenyl-4-carboxylic acid methyl ester；methyl 4'-formylbiphenyl-4-carboxylate；methyl 4′-formyl-[1,1′-biphenyl]-4-carboxylate
• CAS: 70916-89-1
• 化学式: C₁₅H₁₂O₃
• 分子量: 240.258
• InChiKey: URINKTWOCVLGGR-UHFFFAOYSA-N

物化性质

• 熔点：
  112-116 °C
• 沸点：
  398.1±35.0 °C(Predicted)
• 密度：
  1.176±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi,N
• 危险类别码：
  R37/38
• 危险品运输编号：
  UN 3077 9/PG 3
• 海关编码：
  2918300090
• WGK Germany：
  3
• 安全说明：
  S26,S36/37/39,S60,S61
• 包装等级：
  III
• 危险类别：
  9
• 危险性防范说明：
  P261,P273,P280,P305+P351+P338
• 危险性描述：
  H315,H318,H335,H400

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4’-Formylbiphenyl-4-carboxylic acid methyl ester
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H318: Causes serious eye damage
H335: May cause respiratory irritation
H400: Very toxic to aquatic life
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P273: Avoid release to the environment
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 4’-Formylbiphenyl-4-carboxylic acid methyl ester
CAS number: 70916-89-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C15H12O3
Molecular weight: 240.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(4-甲酰苯基)苯甲酸甲酯 在 盐酸 、 palladium 10% on activated carbon 、 盐酸羟胺 、 氢气 、 sodium acetate 作用下， 以 乙醇 、 乙酸乙酯 为溶剂， 20.0~25.0 ℃ 、344.75 kPa 条件下， 反应 37.0h， 生成 methyl 4‘-(aminomethyl)-[1,1‘-biphenyl]-4-carboxylate
  参考文献：
  名称：

  设计和合成针对多发性骨髓瘤体内有效的组蛋白脱乙酰酶、DNA 甲基转移酶 1 和赖氨酸甲基转移酶 G9a 的新型表观遗传抑制剂

  摘要：

  同时抑制与沉默肿瘤抑制基因有关的关键表观遗传途径已被认为是一种有前途的癌症治疗策略。在此，我们报告了一系列首创的基于喹啉的类似物，可同时抑制组蛋白脱乙酰酶（低纳摩尔范围）和 DNA 甲基转移酶-1（中纳摩尔范围，IC 50 < 200 nM）。此外，赖氨酸甲基转移酶 G9a 抑制活性是通过在喹啉环的 7 位引入关键赖氨酸模拟基团实现的（从低纳摩尔范围起）。观察到相应的表观遗传功能细胞反应：组蛋白 3 乙酰化、DNA 低甲基化和组蛋白 3 赖氨酸 9 甲基化减少。这些化学探针（多靶点表观遗传抑制剂）针对多发性骨髓瘤细胞系 MM1.S 进行了验证，证明12a (CM-444) 具有良好的体外活性，GI 50为 32 nM，是一个足够的治疗窗口（>1 个对数单位），和合适的药代动力学特征。在体内， 12a在人类多发性骨髓瘤异种移植小鼠模型中取得了显着的抗肿瘤功效。

  DOI：

  10.1021/acs.jmedchem.0c02255
• 作为产物：
  描述：

  4-氨甲基苯甲酸甲酯盐酸盐 在 N,N-二异丙基乙胺 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 1.0h， 生成 4-(4-甲酰苯基)苯甲酸甲酯
  参考文献：
  名称：

  由无痕连接体引导的无金属芳基交叉偶联。

  摘要：

  无金属、高选择性的联芳基化合物的合成对有机合成提出了重大挑战。报道了一种有前景的（杂）联芳基新方法的范围和机制，该方法通过将芳基取代基与无痕磺酰胺连接体（光剪接）进行光化学融合来实现。用不同的反应条件研究光剪接并对不同的合成探针（40 个例子，包括一组杂环）进行比较表明，该反应具有令人惊讶的广泛范围，并且既不涉及金属也不涉及自由基。量子化学计算表明CC键是通过分子内光化学过程形成的，该过程涉及激发单线态和五元过渡态的遍历，因此具有一致的ipso-ipso耦合结果。这些结果表明，光剪接是一种独特的激发态芳基交叉偶联方法，可用于合成多种联芳基化合物。

  DOI：

  10.1002/chem.201903582

文献信息

• Application of the Fluorous Biphase Concept to Palladium-CatalyzedSuzuki Couplings
  作者：Siegfried Schneider、Willi Bannwarth

  DOI：10.1002/1522-2675(20010321)84:3<735::aid-hlca735>3.0.co;2-l

  日期：2001.3.21

  Suzuki C−C couplings were performed in high yields in a fluorous biphase system applying the four differently perfluoro-tagged Pd complexes 2a – d. All four complexes showed similar catalytic activities in the coupling of electron-rich or electron-deficient bromoarenes 3a – e and arylboronic acids 4a – c (Tables 1 and 2). Furthermore, we were able to show that all four Pd complexes could be recycled

  Suzuki C-C 偶联在含氟双相系统中以高产率进行，应用四种不同的全氟标记 Pd 配合物 2a-d。所有四种配合物在富电子或缺电子溴芳烃 3a-e 和芳基硼酸 4a-c 的偶联中表现出相似的催化活性（表 1 和表 2）。此外，我们能够证明所有四种 Pd 配合物都可以再循环六次，而不会显着降低偶联产率。在一个示例中，我们能够在第一次运行中将四种催化剂的用量从 1.5 mol-% 减少到 0.1 mol-%，但在重复循环中催化剂活性会大大降低（表 3）。
• A Highly Practical and Reliable Nickel Catalyst for Suzuki-Miyaura Coupling of Aryl Halides
  作者：Yu-Long Zhao、You Li、Shui-Ming Li、Yi-Guo Zhou、Feng-Yi Sun、Lian-Xun Gao、Fu-She Han

  DOI：10.1002/adsc.201100101

  日期：2011.6

  functional groups such as ether, ester, ketone, aldehyde, cyano, and unprotected amino and hydroxy groups. Finally, the potential utilization of the methodology was further demonstrated by the gram‐scale synthesis of several core structures of commercialized antihypertensive drugs and fungicides. Thus, the combination of high activity, broad applicability, cheapness, and high stability of NiCl2(dppp)

  我们公开了[1,3-双（二苯基膦基）甲烷]氯化镍（II）[NiCl 2（dppp）]是一种活性高，通用，便宜且稳定的催化剂，可用于芳烃卤化物的铃木-宫浦交叉偶联反应，催化剂负载量低于1 mol％，尤其是在没有额外的支持配体的情况下。在优化的反应条件下，广泛的芳基溴化物以及众所周知的未反应的芳基氯化物，包括活化的，未活化的，失活的，杂芳族的和空间位阻的底物，都可以与各种硼酸顺利偶联（47例，第48页98％的收率）。另外，该转化耐受各种官能团，例如醚，酯，酮，醛，氰基以及未保护的氨基和羟基。最后，克规模的商业化降压药和杀菌剂几个核心结构的合成进一步证明了该方法的潜在用途。因此，NiCl具有高活性，广泛适用性，廉价和高稳定性的组合这项工作中提出的2（dppp）构成了为数不多的突出催化剂之一，这些催化剂使实用，可靠的联芳基和杂联二芳基结构具有易于获得的芳基卤化物和硼酸的结构多样性。
• [EN] NOVEL COMPOUNDS FOR USE IN CANCER<br/>[FR] NOUVEAUX COMPOSÉS DESTINÉS À ÊTRE UTILISÉS POUR LE CANCER
  申请人：FUNDACION PARA LA INVESTIG MEDICA APLICADA

  公开号：WO2018229139A1

  公开（公告）日：2018-12-20

  It relates to the compounds of formula (I), or their pharmaceutically or veterinary acceptable salts, or their stereoisomers or mixtures of stereoisomers, wherein X, L,R1, R 2, and R 3 are as defined herein, which are cancer cell differentiation inducing agents. It also relates to pharmaceutical or veterinary compositions containing them, and to their use in medicine, in particular in the treatment and/or prevention of cancer, in particular by cell differentiation therapy.

  本发明涉及式(I)的化合物，或其药物或兽药可接受的盐，或其立体异构体或立体异构体混合物，其中X、L、R1、R2和R3如本文所述定义，它们是癌细胞分化诱导剂。本发明还涉及含有它们的药物或兽药组合物，以及它们在医学中的应用，特别是在通过细胞分化疗法治疗和/或预防癌症中的应用。
• Droplet‐based Continuous Flow Synthesis of Palladium Supported on Reduced Graphene Oxide
  作者：Yea Seul Jang、Su Min Nam、Go Eun Son、Jihoon Lee、Chan Pil Park

  DOI：10.1002/bkcs.11966

  日期：2020.3

  Pd‐RGO synthesis using droplet‐based continuous flow reactor.

  使用基于液滴的连续流反应器进行Pd-RGO合成。
• Sublimable bis( β -iminoenolate)palladium(II) complexes and their application as catalysts in Suzuki-Miyaura reactions
  作者：Mi Jin Kim、Myung Jin Jung、Yeong Joon Kim、Ha Kyoung Sung、Ju Young Lee、Sung Jin Ham、Chan Pil Park

  DOI：10.1016/j.tetlet.2018.06.051

  日期：2018.8

  The Pd(II) complexes strongly chelated by two β-iminoenolate ligands were easily synthesized in only two steps, and purified based on their sublimable and highly stable property. The Pd(II) complexes anchored on a silica surface showed good catalytic activity in Suzuki-Miyaura reactions (up to 99% yield with 0.05 mol% catalyst). They tolerated a wide range of temperature (rt∼110 °C) and various solvents

  被两个β-亚氨基烯酸酯配体强烈螯合的Pd（II）络合物仅需两步即可轻松合成，并基于其可升华和高度稳定的特性进行纯化。锚固在二氧化硅表面的Pd（II）配合物在Suzuki-Miyaura反应中显示出良好的催化活性（使用0.05 mol％的催化剂，收率可达99％）。它们耐受温度范围广（rt〜110°C）和各种溶剂，并且经过简单的回收过程即可重复使用多次。